IPR2023-00249 - Dana Farber Cancer Institute Inc v. Bristol Myers Squibb CoReport Error
Details
PATENT NUMBER
APPL. NUMBER
16006493
STATUS
Settlement
FILING DATE
2022-12-29
INSTITUTION DATE
N/A
TERMINATION DATE
2023-04-10
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Motion to Terminate
Final Decision
Dec
2023
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2024
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2025
Feb
Mar
Apr
May
Docket
1 | 2022-12-29 | Petitioner | Petition | Petition for Inter Partes Review |
2 | 2022-12-29 | Petitioner | Power of Attorney | Petitioner's Power of Attorney |
1001 | 2022-12-29 | Petitioner | U.S. Patent No. 10,323,092 B2 | |
1002 | 2022-12-29 | Petitioner | Declaration of Dr. Salma Jabbour | |
1003 | 2022-12-29 | Petitioner | Declaration of Robert Paarlberg | |
1004 | 2022-12-29 | Petitioner | Curriculum vitae of Dr. Salma Jabbour | |
1005 | 2022-12-29 | Petitioner | Curriculum vitae of Robert Paarlberg | |
1006 | 2022-12-29 | Petitioner | List of Materials Considered by Dr. Salma Jabbour | |
1007 | 2022-12-29 | Petitioner | List of Materials Considered by Robert Paarlberg | |
1008 | 2022-12-29 | Petitioner | June 8, 2022, Letter to Hon. Kathi Vidal from Senators Leahy, Cornyn,... | |
1009 | 2022-12-29 | Petitioner | U.S. Patent 7,595,048 | |
1010 | 2022-12-29 | Petitioner | U.S. Application No. 16/006,493 | |
1011 | 2022-12-29 | Petitioner | U.S. Provisional Application No. 61/647,442 | |
1012 | 2022-12-29 | Petitioner | U.S. Provisional Application No. 61/790,747 | |
1013 | 2022-12-29 | Petitioner | Okazaki 2007 | |
1014 | 2022-12-29 | Petitioner | Iwai 2002 | |
1015 | 2022-12-29 | Petitioner | Blank 2005 | |
1016 | 2022-12-29 | Petitioner | Iwai 2004 | |
1017 | 2022-12-29 | Petitioner | Brown 2003 | |
1018 | 2022-12-29 | Petitioner | Ascierto 2010 | |
1019 | 2022-12-29 | Petitioner | Brahmer | |
1020 | 2022-12-29 | Petitioner | NCT ’842 | |
1021 | 2022-12-29 | Petitioner | NCT664 | |
1022 | 2022-12-29 | Petitioner | Hwu 2010 | |
1023 | 2022-12-29 | Petitioner | Mu | |
1024 | 2022-12-29 | Petitioner | File History for U.S. Patent No. 10,323,092 B2 | |
1025 | 2022-12-29 | Petitioner | Topalian 2011 | |
1026 | 2022-12-29 | Petitioner | Topalian 2012 | |
1027 | 2022-12-29 | Petitioner | PCT Publication No. WO 2007/005874 A2 | |
1028 | 2022-12-29 | Petitioner | Tuthill 2009 | |
1029 | 2022-12-29 | Petitioner | Sznol 2010 | |
1030 | 2022-12-29 | Petitioner | U.S. Publication No. US 2010/0055102 A1 | |
1031 | 2022-12-29 | Petitioner | Erbitux Label | |
1032 | 2022-12-29 | Petitioner | Vectibix Label | |
1033 | 2022-12-29 | Petitioner | Tysabri Label | |
1034 | 2022-12-29 | Petitioner | Feb. 29, 2000 NIH Press Release | |
1035 | 2022-12-29 | Petitioner | ClinicalTrials.gov History, Policies, and Laws | |
1036 | 2022-12-29 | Petitioner | U.S. NAT’L LIBRARY OF MED., NAT’L INST. OF HEALTH, ClinicalTrials.gov... | |
1037 | 2022-12-29 | Petitioner | ClinicalTrials.gov Home Page | |
1038 | 2022-12-29 | Petitioner | NCT 664 Protocol | |
1039 | 2022-12-29 | Petitioner | August 4, 2008 vs October 27,2009 comparison | |
1040 | 2022-12-29 | Petitioner | Lee | |
1041 | 2022-12-29 | Petitioner | ClinicalTrials.gov, How to Edit Your Study Record | |
1042 | 2022-12-29 | Petitioner | ClinicalTrials.gov, Background | |
1043 | 2022-12-29 | Petitioner | ClinicalTrials.gov, Glossary | |
1044 | 2022-12-29 | Petitioner | NCT664 Key Record Dates | |
1045 | 2022-12-29 | Petitioner | NCT664 Landing Page | |
1046 | 2022-12-29 | Petitioner | August 4, 2008 vs April 17, 2009 comparison | |
1047 | 2022-12-29 | Petitioner | August 4, 2008 vs June 24, 2009 comparison | |
1048 | 2022-12-29 | Petitioner | August 4, 2008 vs January 19, 2011 comparison | |
1049 | 2022-12-29 | Petitioner | U.S. Patent No. 10,308,714 | |
1050 | 2022-12-29 | Petitioner | U.S. Patent No. 10,266,594 | |
1051 | 2022-12-29 | Petitioner | Jemal et al., Cancer Statistics, 2009, 59 CA Cancer J. Clin. 225 (2009) | |
1052 | 2022-12-29 | Petitioner | Konishi 2004 | |
1053 | 2022-12-29 | Petitioner | U.S. Publication No. US 2009/0055944 A1 | |
1054 | 2022-12-29 | Petitioner | U.S. Publication No. US 2011/0250201 A1 | |
1055 | 2022-12-29 | Petitioner | U.S. Publication No. US 2011/0244546 A1 | |
1056 | 2022-12-29 | Petitioner | What is Non-Small Cell Lung Cancer? American Cancer Society (2016) | |
1057 | 2022-12-29 | Petitioner | Auperin 2010 | |
1058 | 2022-12-29 | Petitioner | U.S. Publication No. US 2010/0203056 A1 | |
1059 | 2022-12-29 | Petitioner | U.S. Patent No. 9,580,505 | |
1060 | 2022-12-29 | Petitioner | U.S. Patent No. 9,580,507 | |
1061 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1062 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1063 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1064 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1065 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1066 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1067 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1068 | 2022-12-29 | Petitioner | Intentionally Omitted | |
1069 | 2022-12-29 | Petitioner | Brahmer 2012 | |
1070 | 2022-12-29 | Petitioner | December 5, 2022, Letter to Hon. Kathi Vidal from Senators Warren and... | |
3 | 2023-01-13 | Board | Notice of Filing Date | Notice: Notice filing date accorded |
2023-01-19 | Potential Patent Owner | Mandatory Notice | Notice : Mandatory Notice | |
4 | 2023-01-19 | Potential Patent Owner | Mandatory Notice | Notice : Mandatory Notice |
5 | 2023-01-19 | Potential Patent Owner | Power of Attorney | Notice : Power of Attorney |
6 | 2023-02-03 | Petitioner | Other | Petitioner Dana-Farber Cancer Institute, Inc.'s Unopposed Motion for Pro Hac Vice Admission of Katherine A. Helm, J.D., Ph.D. |
7 | 2023-02-03 | Petitioner | Other | Petitioner Dana-Farber Cancer Institute, Inc.'s Unopposed Motion for Pro Hac Vice Admission of Noah M. Leibowitz |
1071 | 2023-02-03 | Petitioner | Declaration of Katherine A. Helm in Support of Motion for Admission Pro Hac Vice | |
1072 | 2023-02-03 | Petitioner | Declaration of Noah M. Leibowitz in Support of Motion for Admission Pro Hac Vice | |
8 | 2023-02-28 | Board | Other | DECISION Granting Petitioners Motions for Pro Hac Vice Admission of Katherine A. Helm and Noah M. Leibowitz 37 C.F.R. sec 42.10 |
9 | 2023-04-06 | Petitioner | Motion to Terminate | Joint Motion to Terminate Pursuant to 35 U.S.C. § 317 |
10 | 2023-04-06 | Petitioner | Other | Joint Request that the Settlement Agreement be Treated as Business Confidential Information Pursuant to 35 U.S.C. § 317 |
3001 | 2023-04-06 | Board | Exhibit 3001 | |
11 | 2023-04-10 | Board | Final Decision | Termination Decision: Pre-DI settlement |
12 | 2023-04-11 | Petitioner | Other | Petitioner's Request for Refund of Post-Institution Fees |
13 | 2023-04-17 | Board | Other | Notice: refund approved |
Grounds Asserted